Chlorure de phénoxybenzamine, >=97%, poudre

Code: b019-250mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Calmodulin antagonist; α-adrenoceptor antagonist.

Features and Benefits

This compound was developed by Wellspring. T...


en savoir plus

Votre prix
£97.30 250MG
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Calmodulin antagonist; α-adrenoceptor antagonist.

Features and Benefits

This compound was developed by Wellspring. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

Packaging

250 mg in glass bottle

assay≥97%
colorwhite
formpowder
Gene Informationhuman ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152)
InChI keyVBCPVIWPDJVHAN-UHFFFAOYSA-N
InChI1S/C18H22ClNO.ClH/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17;/h2-11,16H,12-15H2,1H3;1H
originatorWellspring
Quality Level100
SMILES stringCl[H].CC(COc1ccccc1)N(CCCl)Cc2ccccc2
solubilityH2O: slightly soluble, alcohol: soluble, propylene glycol: soluble
storage temp.2-8°C
Cas Number63-92-3
Ce produit répond aux critères suivants: